StockCIK 715446
Anixa Biosciences Inc (ANIX): Insider Trades and Fund Holdings
In the past 12 months, Anixa Biosciences Inc insiders reported 9 open-market purchases worth $276K and 0 sales worth $0.
9Insider buys, 12 months
$276KBought by insiders, 12 months
$0Sold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 26 | Lewis H. Titterton JrDirector | ▲ BUY | $24K |
| Oct 22 | Amit KumarCEO | ▲ BUY | $22K |
| Sep 30 | Michael CatelaniCFO | ▲ BUY | $16K |
| Sep 28 | Amit KumarCEO | ▲ BUY | $19K |
| Sep 28 | Arnold M. BaskiesDirector | ▲ BUY | $14K |
| Sep 25 | Lewis H. Titterton JrDirector | ▲ BUY | $132K |
| Sep 14 | Lewis H. Titterton JrDirector | ▲ BUY | $27K |
| Sep 14 | Amit KumarCEO | ▲ BUY | $8K |
| Sep 11 | Amit KumarCEO | ▲ BUY | $14K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Lewis H. Titterton Jr | Director | 3 | $183K | 0 | $0 |
| Amit Kumar | CEO | 4 | $63K | 0 | $0 |
| Michael Catelani | CFO | 1 | $16K | 0 | $0 |
| Arnold M. Baskies | Director | 1 | $14K | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report ANIX
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 59,373 | $166K | ▼ −2.9% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →